Dr. Mulford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# Box
Rochester, NY 14642Phone+1 585-275-0784Fax+1 585-273-5761
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
NYU Grossman School of MedicineResidency, Internal Medicine, 1999 - 2002
University of Rochester School of Medicine and DentistryClass of 1999
Certifications & Licensure
NY State Medical License 2001 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
Publications & Presentations
PubMed
- 1618 citationsPembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara
Lancet. 2019-11-23 - 72 citationsNotch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.Nitin Roper, Moises J. Velez, Alberto Chiappori, Yoo Sun Kim, Jun Wei
Nature Communications. 2021-06-23 - 45 citationsHeterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models.Delphine Lissa, Nobuyuki Takahashi, Parth Desai, Irena Manukyan, Christopher W Schultz
Nature Communications. 2022-04-19
Press Mentions
Patient with Stage 4 ALK-Positive Lung Cancer Hasn’t Skipped a Beat, Thanks to Targeted TherapyNovember 4th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
